Novel mPGES-1 inhibitors as next generation of anti-inflammatory drugs - 2122
- 技術優勢
- Inventioninhibits mPGES-1 activity with greater potency than mPGES-1 inhibitors in orderto treat inflammatory disorders. Invention should limit adverse side effectsassociated with traditional anti-inflammatory agents (i.e. ulcers,gastrointestinal bleeding).
- 詳細技術說明
- None
- *Abstract
-
None
- 國家/地區
- 美國
欲了解更多信息，請點擊 這裡
